Dr. Duvallet earned her PhD in biology from University Paris 13 in France (2012). Dr. Duvallet then did a two year post-doctoral fellowship at Gustave Roussy where she worked in immunology and cancer. Dr. Duvallet’s role is to develop treatments for both cancer and autoimmune diseases. In cancer, she explores the possible utility of a Veroscience PDT photosensitizer against non-immunogenic pancreatic cancer and the generation of a targeted PDT-induced immune-assisted anti-tumor response.
Creators of Cycloset®*, the first and only FDA approved sympatholytic dopamine D2 receptor agonist for the treatment of type 2 diabetes.
*See full prescribing info
